×

RNS Number : 1569W

EU Supply PLC

17 August 2015

 

17 August 2015

EU Supply plc

("EU Supply", the "Company" or "the Group")

 

Contract win

 

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce that it has

been awarded a long term contract with Oslo Kommune (Capital City Council of Norway), in  competition with several of its main competitors in Norway. The contract allows the city council central procurement and any of its subsidiaries the right to use the Company's CTMTM platform.

 

The contract is a 6 years fixed contract, with up to 2 years optional extensions, and is expected to lead to more than 50 organisational units and up to 800 users using the CTMTM platform by the time the new EU Directives are expected to become effective in Norway. Fees depend on the number of users of each module of the service. This is the third European capital city contract awarded to the Company in the last three months.

 

This agreement underpins the Company`s development in multiple markets and confirms management's confidence in growth for 2015 and beyond.

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Mattias Ström, CFO   Westhouse Securities Tel: 020 7601 6100 Tom Griffiths, David Coaten

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for e-sourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 7,000 European public sector bodies in 10 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013 when the Company raised £5.0 million before expenses. In July 2014, the Company raised a further £1.35 million by way of a placing of new ordinary shares, the proceeds of which were mainly used to strengthen the Company's balance sheet, provide working capital to support the growth of the business as it expands and aims to gain market share and to provide additional funds for sales and marketing.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTQZLFFEVFBBBZ

Close

×

RNS Number : 1404W

Netcall PLC

17 August 2015

 

17 August 2015

RNS Reach

Netcall plc

("Netcall" or the "Company")

Contract Win

Largest SaaS contract for new Liberty platform

 

Netcall plc (AIM: NET), a leading customer engagement software provider, is pleased to announce that it has secured a five-year SaaS contract worth a minimum of £1.4 million to provide its Liberty multi-channel contact centre and unified communication solutions.

 

As part of the agreement Netcall will deliver a range of inbound and outbound voice, email and chat applications that utilise Liberty's business process management capabilities for workflow automation and data integration with legacy systems. This will enable the client to deliver a consistent, personalised customer experience and achieve efficiencies. Netcall's solution will replace a number of legacy on-premise systems with a hosted solution that provides a virtual contact centre for the client's six sites.

 

Henrik Bang, CEO of Netcall commented: "Today's announcement represents a milestone for Netcall as it is the largest SaaS contract we have been awarded for our new Liberty platform.

 

"The end-to-end, fully hosted solution will transform the way in which our client interacts with its customers and we look forward to working with them."

 

For further enquiries, please contact:

 

Netcall plc	Tel. +44 (0) 330 333 6100
Henrik Bang, CEO Michael Jackson, Chairman James Ormondroyd, Group Finance Director
finnCap Limited (Nominated Adviser and Broker)	Tel. +44 (0) 20 7220 0500
Stuart Andrews / James Thompson, Corporate Finance
Simon Johnson, Corporate Broking
Alma PR	Tel. +44 (0) 7780 901979
Josh Royston / Hilary Buchanan	+44 (0) 7515 805218

 

 

 

About Netcall plc

 

Netcall is a UK company quoted on the AIM market of the London Stock Exchange. Netcall's software product suite provides compelling business process solutions for end-to-end customer engagement, incorporating multi-channel contact centre, workforce optimisation, business process management and enterprise content management. The Netcall software platform helps organisations meet the growing demands of their customers and prospects whilst improving internal efficiencies, thereby increasing profitability and customer satisfaction.

 

Netcall's customer base contains over 700 organisations in both the private and public sectors. These include two thirds of NHS Acute Health Trusts, major telecoms operators such as BT and leading organisations including Interflora, Lloyds Banking Group, Cineworld, Interserve, Prudential, British Sugar and Thames Water.

 

For further information, please consult the Netcall website: www.netcall.com 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRASFAFDLFISELA

Close

×

RNS Number : 9085V

Transense Technologies PLC

13 August 2015

 

13th August 2015

 

 Transense Technologies plc

("Transense" or the "Company")

 

New Translogik iTrack Contract Win in Australia

Transense Technologies plc (AIM: TRT), the provider of sensor systems for the transportation and industrial markets, is pleased to announce that its trading division, Translogik, has won another contract through its Australian partner, Brownfield Engineering & Maintenance PTY LTD ("Brownfield").

The agreement is to supply 47 iTrack mining tyre monitoring systems for large haul trucks to the Saraji coal mine in the Bowen Basin, Queensland, owned by the BHP Billiton Mitsubishi Alliance (BMA). The contract includes the sale of equipment on a finance lease. In addition to the sale there will be income from service and rental for a minimum period of two years.

Graham Storey, CEO of Transense said "This is another significant contract win for Translogik's iTrack system in quick succession, after other recent wins with Glencore in Australia, and BHP in Chile. The new strategy of offering a range of payment methods, including rental and finance lease, appears to have eased the barrier to large-scale adoption within the mining industry and we look forward to  further agreements in due course. "

Darryl Crowder, Managing Director of Brownfield said "The important role of tyre monitoring as part of a total safety and performance monitoring strategy within the mining sector is an increasingly major focus in Australia. We have received significant interest in the iTrack system due to its accuracy and ease of use compared to competing systems, and I am confident that this high level of enquiries will translate into further uptake."

 

For further information, please contact:

 

Transense Technologies plc Graham Storey, Chief Executive	Tel: +44 1869 238 380
finnCap Ed Frisby, Giles Rolls (Corporate Finance) Tony Quirke, Alice Lane (Corporate Broking)	Tel: +44 20 7220 0500
IFC Advisory Tim Metcalfe, Graham Herring, Heather Armstrong	Tel: +44 20 3053 8671

 

About Transense Technologies

 

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW) wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the global electrical Smart Grid applications market, the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its three trading divisions, IntelliSAW, Translogik and SAWSense, respectively.

 

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: "TRT").

 

www.transense.co.uk

 

About Translogik

 

Translogik, a trading division of Transense Technologies plc, is a provider of innovative tyre management solutions for the OTR (Off-the-Road), commercial and passenger vehicle markets.

 

The product portfolio includes wireless tyre temperature & pressure monitoring systems, tread depth, pressure and temperature data collection tools for truck, bus and OTR vehicle tyre inspections, and RFID (Radio Frequency Identification) tags, patches and UHF readers for tyres and general asset tracking.

 

The Products have been designed to operate in the most hostile and demanding environments, such as mining, earth-moving and construction.

 

www.trans-logik.com

 

About iTrack

 

Translogik's iTrack system provides a rugged and reliable solution with a range of features that allows mine operators to track their vehicle's tyre temperature and pressure, speed, braking and location in real-time and receive early warning of potential problems or hazards.

The availability of live tyre and vehicle data allows swift remedial action to be taken, which can be the difference between safe mine operation and a major incident. By ensuring the vehicle's tyres are operating within recommended temperature and pressure limits, iTrack brings increased levels of safety to both the vehicle drivers and the technicians that work on them. In addition, the system allows for multiple concurrent geo-fence zones to be defined to ensure that vehicles are only operating in approved areas, further increasing the safety of the mine.

From a commercial perspective, by ensuring that tyres are correctly inflated and managed, tyre life is extended, fuel economy is improved and costly down-time from repairs and intervention is reduced, improving productivity. TKPH (Ton Kilometre Per Hour) calculations using loaded/unloaded weights and real-time route cycling allows tyres to be run at higher efficiency based on their TKPH rating (based on size, construction type, rubber compound and hours usage) without overheating or causing premature deterioration.

Alarms trigger when user configurable operational threshold levels, such as tyre temperature, are exceeded, providing early warning of potential tyre or vehicle failure.

About Brownfield Engineering and Maintenance PTY LTD

 

Brownfield provides maintenance and operational support to major mining companies. With three facilities strategically positioned in the Bowen Basin, Hunter Valley & Perth – Australia's premier mining locations. 

 

Brownfield was formed with a focus on supporting the working assets of the mining sector and has been integrated into three key services offerings: 

 

·     Products: mining and associated products

·     Engineering: engineering services to the mining industry

·     Maintenance: mining maintenance services

 

http://www.brownfield.com.au/home/

 

About Saraji Mine

 

The Saraji Coal Mine is a coal mine located near Dysart in the Central Queensland region of Australia. The mine has coal reserves amounting to 648 million tonnes of coking coal, one of the largest coal reserves in the world. The mine has an annual production capacity of 5 million tonnes of coal. It is located in the Bowen Basin an area with significant coal deposits and numerous mines.

 

Saraji mine utilises open-cast extraction methods. It is owned by the BHP Billiton/Mitsubishi Alliance (BMA). The mine has a total of 11 coal seams.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTPKBDKFBKDPFD

Close

×

RNS Number : 7648V

Netplay TV PLC

12 August 2015

 

 

Date:	12 August 2015
On behalf of:	NetPlay TV plc ('the Company') along with its subsidiaries (the 'Group' or 'NetPlay' or 'NetPlay TV')
Embargoed until: 0700hrs

 

NetPlay TV plc

Acquisition of Digital Marketing Business

 

NetPlay TV (AIM: NPT), the interactive gaming company, is pleased to announce the acquisition of Otherside Inc. ("Otherside"), an online marketing, product development and technology company, for a total consideration of £3.2m (the "Acquisition").

 

Strategic rationale for the Acquisition

The Board has been actively looking at the market and considering various options as part of its stated strategy to expand the business both organically and through M&A. The Board believes the acquisition of Otherside will provide NetPlay with a number of key benefits, including;

 

·     A robust media platform and specialist staff enabling the Group to control and tailor its digital marketing strategies.

 

·     Synergies within the Group's existing gaming operations, delivering additional traffic to the Group's existing brands as well as a marketing skillset complimentary to its core products.

 

·   The diversification of NetPlay's revenue by maintaining Otherside's current revenue streams and growing this business by building on the success of the marketing company to date.

 

Information on Otherside

Founded in 2008, Otherside specialises in online marketing, display media and affiliation, underpinned by its proprietary online marketing platform across a range of sectors. Otherside generated revenues of £2.6m, Adjusted EBITDA* of £0.6m and profit before tax of £0.4m in its unaudited financial information for the financial year ended 31 May 2015. This transaction constitutes a substantial transaction under the AIM Rules.

 

Terms of the Acquisition

The consideration for the Acquisition, for the trade and assets of Otherside, comprises an initial consideration of £2.7 million, to be satisfied by a cash payment from the Group's existing cash resources. Further consideration of £0.5 million is payable over 12 months from date of completion subject to the vendor completing certain deliverables as well as the continued employment of certain key individuals.

 

 

 

Bjarke Larsen, Chief Executive Officer of NetPlay TV commented:

"I am delighted to announce the acquisition of Otherside, which will strategically align with our core business and support our digital strategy across the Group's brand portfolio. As previously stated, NetPlay is in a strong position to pursue appropriate, value-enhancing M&A activity and we are confident that this acquisition further strengthens the Group's digital reach. We look forward to integrating this specialist team into our operations and capitalising on the numerous commercial and margin-enhancing opportunities presented by the acquisition."

 

Enquiries:

NetPlay TV plc	www.netplaytv.com
Bjarke Larsen, Chief Executive Officer   Akshay Kumar, Group Finance Director	Via Redleaf
Redleaf Communications	Tel: 020 7382 4730
Rebecca Sanders-Hewett Susie Hudson	netplay@redleafpr.com
Shore Capital (Nominated Adviser and Broker)	Tel: 020 7408 4090
Stephane Auton Edward Mansfield

Notes to Editors:

About NetPlay TV plc

NetPlay TV plc is admitted to trading on the AIM market of the London Stock Exchange (NPT). The Group operates a number of interactive gaming services under a UK remote operating license and Alderney gaming license, including SuperCasino.com, Jackpot247.com and Vernons.com. Its TV services can also be viewed 24 hours a day live on Sky Channel 862, and every evening on ITV and Channel 5.

The Company is focused on the delivery of a converged interactive gaming experience allowing its players to interact with its games on a variety of platforms, TV, internet, mobile and tablet from a common integrated wallet.

About OtherSide Inc.

OtherSide Inc. is a team of marketing experts, creative people, programmers and business professionals whose main goal is to create, implement and uphold new and better ideas to market products and services in the Internet.

Founded in 2008, OtherSide Inc. has committed to the newest, most advanced and best performing solutions for online marketing in order to maximize exposure, revenues and optimize campaigns for best ROI.

OtherSide Inc. specializes in all the phases of the online marketing, including product development, site and funnel building, infrastructure and technology, design, creativity, media buying and optimisation, and customer service.

 

---

[*] Adjusted EBITDA is non-GAAP company specific measure

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

ACQEFLFFEVFZBBV

Close

×

RNS Number : 7988V

Oxford Pharmascience Group PLC

12 August 2015

 

 

Oxford Pharmascience Group plc

("Oxford Pharmascience" or the "Company")

 

Preliminary Pharmacokinetic Data and
Initiation of Pilot Clinical Study

to Demonstrate Improved GI Profile for OXPzero™ Ibuprofen

 

Oxford Pharmascience Group Plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, today announces that preliminary pharmacokinetic (PK) data confirms that OXP001(2) has successfully met its optimisation objectives for immediate release and complete drug absorption. The Company has commenced dosing in the second phase of the study, which seeks to prove the reduced gastro-intestinal (GI) irritation benefit of OXPzero™ Ibuprofen by endoscopic evaluation.

 

The randomized pilot PK study was a single-dose, two-arm UK study comparing the OXP001(2) 400mg chewable OXPzero™ Ibuprofen tablet and the reference Brufen® 400mg tablet (ibuprofen), in ten subjects. Preliminary PK data show comparable AUC (Area Under the Curve or total drug exposure over time) and tmax (time to reach maximum serum concentration) results, demonstrating that OXP001(2) is now a product with immediate and complete drug release characteristics. While the PK profile of the product appears to be similar to that of Brufen® on these measures, the maximum level of drug concentration in plasma (Cmax) appears to be lower compared to Brufen® but remains well within the range which the drug has therapeutic effect. The Company believes this preliminary PK data represents an acceptable clinical profile suitable for commercialisation.  Additional PK data will be collected during the next phase of the study.

 

The taste masked benefit of OXPzero™ Ibuprofen was also assessed via subject interviews, during the first phase of this study, with consistent feedback confirming that the chewable tablets were tasteless, with none of the burn or after-taste issues associated with standard ibuprofen.

 

Following analysis of the preliminary PK data, the Company is proceeding to the second phase of the study, which aims to demonstrate a significantly reduced GI side effect profile compared to standard 400mg Brufen® tablets.  The product to be tested, OXP001(2), is a 400mg chewable, taste masked, oral formulation of ibuprofen.

 

This phase of the study is a randomised, assessor-blinded, controlled pilot clinical study to assess the severity of upper GI damage via endoscopic assessment following 7 days' treatment of 2.4g/day of ibuprofen dosed as either OXP001(2) or Brufen®. A prior study in 2014 demonstrated significant GI side-effect benefits, compared to Brufen®, using an early version of OXP001 for which the PK profile has since been optimised for immediate release and complete drug absorption. Headline results on the second phase are expected to be released in Q4 2015, along with complete PK data and further taste masking assessments.

 

Marcelo Bravo, Chief Executive Officer, commented:

"We are pleased to confirm that OXP001(2) now achieves immediate release and complete drug absorption in vivo and that the taste masking benefit of the technology has been validated.  We are confident the product is achieving release properties in line with the objective of delivering a reduction in GI irritation. Demonstrating that OXP001(2) achieves a significant reduction in GI erosions compared to Brufen® in this new formulation will validate OXPzero™ Ibuprofen as a disruptive compound in the major $4bn ibuprofen market."

 

Further details about the study can be found at www.ClinicalTrials.gov. 

 

For further information:

Oxford Pharmascience Group Plc
Marcelo Bravo, Chief Executive	+44 20 7 554 5875
N+1 Singer (Nominated Adviser & Broker)
Aubrey Powell/Jen Boorer	+44 20 7496 3000

 

About Oxford Pharmascience Group Plc

Oxford Pharmascience Group Plc uses a range of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take. The Company does not manufacture or sell its own pharmaceutical products direct to consumers but instead seeks to license its technologies and dossiers to a network of partners, mainly leading pharmaceutical companies with Rx (prescription) and OTC (Over the Counter) branded portfolios.

 

Oxford Pharmascience Group Plc focuses on existing medicines that are proven to be safe and effective but nevertheless still have associated issues and side effects often affecting compliance. By working with such medicines the Company is able to develop new innovative products for a fraction of the cost, in much quicker timescales and without the high risk of failure associated with developing new drugs.

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCEASPAFLPSEEF

Close

×

RNS Number : 6394U

Obtala Resources Limited

31 July 2015

 

 

 

31 July 2015

Obtala Resources Limited

("Obtala" or the "Company")

 (AIM: OBT)

 

Farm Certification: Tanzania

 

Obtala Resources Limited (AIM:OBT), the vertically integrated agribusiness, timber and retail company, is pleased to announce that it has be awarded the internationally recognized farm GLOBALG.A.P. certification for its agricultural operations in Tanzania.

 

The Company has received notification from our consultants that the GLOBALG.A.P. Certification has been awarded to our farming operation in Tanzania. This is a significant milestone for the Company and overcomes a barrier to entry with many international food groups.

 

GLOBALG.A.P. is the internationally recognized standard for farm production. The core product standard is the result of years of intensive research and collaboration with industry experts, producers and retailers around the globe. The goal is safe and sustainable agricultural production to benefit farmers, retailers and consumers throughout the world.

 

GLOBALG.A.P. Certification covers:

 

·     Food safety and traceability

·     Environment (including biodiversity)

·     Workers' health, safety and welfare

·     Animal welfare

·     Includes;

o  Integrated Crop Management (ICM),

o  Integrated Pest Control (IPC),

o  Quality Management System (QMS), and

o  Hazard Analysis and Critical Control Points (HACCP)

 

GLOBALG.A.P. demands, among other things, greater efficiency in production. It improves business performance and reduces waste of vital resources. It also requires a general approach to farming that builds in best practices for generations to come.

 

We continue to address additional requirements to secure BRC Global Standards Certification for the processing unit, which will allow us to export internationally to food producers, wholesalers and retailers. An audit inspection was conducted in late June and a certification audit is expected in October 2015.

 

Commenting on today's announcement, Francesco Scolaro, Chairman of Obtala, said: "As a Board we are very pleased to have gained the GLOBALG.A.P. certification. The award is the result of much hard work and time ensuring full compliance with required international food safety standards. I personally want to thank the team on the ground for their efforts as we can now access new market opportunities for our projects, which will have a positive impact on the Company and importantly the local community in Tanzania. We are working towards BRC Global Standards Certification on the processing unit and hope to have the certification audit in October. The award of these certificates, coupled with the Export Processing Zone ("EPZ") Award, received in late 2014, will greatly enhance market opportunities for the farm and processing unit, in a highly attractive business sector which is expected to continue experiencing strong growth. I look forward to updating shareholders in due course."

 

 

 

Obtala Resources Francesco Scolaro – Chairman Simon Rollason – Managing Director   www.obtalaresources.com	+44 (0)20 7099 1940
ZAI Corporate Finance Limited (Nomad)	+44 (0)20 7060 2220
Ray Zimmerman Richard Morrison
Brandon Hill Capital  (Broker)	+44 (0)20 3463 5000
Jonathan Evans
Square 1 Consulting (Public Relations)	+44 (0)20 7929 5599
David Bick Mark Longson

 

 

Other information:

 

GLOBALG.A.P. 

"Putting Food Safety and Sustainability on the Map"

 

http://www.globalgap.org

 

G.A.P. stands for Good Agricultural Practice – and GLOBALG.A.P. is the worldwide standard that assures it.

 

GLOBALG.A.P. is a global organization with a crucial objective: safe, sustainable agriculture worldwide. GLOBALG.A.P. sets voluntary standards for the certification of agricultural products around the globe-and more and more producers, suppliers and buyers are harmonizing their certification standards to match.

 

The purpose of GLOBALG.A.P. is to create private sector incentives for agricultural producers worldwide to adopt safe and sustainable practices to make this world a better place to live in for our children. Globally connecting farmers and brand owners in the production and marketing of safe food to provide reassurance for consumers. GLOBALG.A.P. lays the foundation for the protection of scarce resources by the implementation of Good Agricultural Practices with a promise for a sustainable future.

 

BRC Global Standards

http://www.brcglobalstandards.com/

 

BRC Global Standards is a leading safety and quality certification programme, used by over 22,000 certificated suppliers in 123 countries, with certification issued through a worldwide network of accredited certification bodies.

 

The Standards guarantee the standardisation of quality, safety and operational criteria and ensure that manufacturers fulfil their legal obligations and provide protection for the end consumer. BRC Global Standards are now often a fundamental requirement of leading retailers.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

STRWGUBGMUPAGQU

Close

×

RNS Number : 6441U

BMR Mining PLC

31 July 2015

 

BMR Mining PLC

("BMR" or the "Company")

Significant Testing Progress Update

 

BMR Mining PLC, the Zambian-focused mineral processing business, is pleased to announce significant progress on its testing results.

 

Highlights:

 

–       Wash Plant Tailings demonstrate materially increased lead and zinc recoveries during additional laboratory optimisation testing;

 

–       successful recovery of lead and zinc products by precipitation and electro winning from the pregnant liquor solution;

 

–       potential recovery of 77% of zinc from Imperial Smelting furnace slag, a resource that was previously written off;

 

–       recognising positive metallurgical work undertaken, the Company intends to commence pilot processing plant operations this financial year.

 

Alex Borrelli, CEO and Chairman, commented:

"We are delighted to have achieved positive progress across our recent metallurgical testing which could significantly enhance the inherent value of the Company's commercial interests going forward.  While shareholders should be aware that the results of the laboratory tests may not be matched by commercial processing, we are confident that the processes are scalable and we will move quickly through to the pilot plant stage of evaluation.

"As shareholders will likely appreciate there is still further work to undertake but receiving this positive data at this stage makes a tremendous difference and greatly encourages the BMR team.

"We are enthusiastically pushing forward and further operational news updates will follow in the near term as the Company continues its work."

 

Wash Plant Tailings

The Company is pleased to announce that, following further laboratory testing, our optimisation of the proposed acid/brine leach process has resulted in the possibility of achieving higher metal recoveries from the Wash Plant Tailings (WPT) than previously reported.

The WPT was estimated by Mineral Corporation Consultancy (Pty), in its March 2012 report, to contain 573,458 dry tonnes (JORC compliant) at a mean grade of 10.66% Zn and 7.21% Pb (61.4kt contained Zn and 41.3kt contained Pb).

The potential lead and zinc recoveries that have been achieved into a Pregnant Liquor Solution (PLS) are 94.2% Pb and 79.6% Zn. These higher recoveries compare favourably with the earlier test results announced of 80% Pb and 70% Zn for the WPT and proving the commercial viability of scaling this new process will be the next stage of our evaluation.

This test work was carried out in conjunction with the Company's Mineral Processing Partner in its metallurgical test laboratory and was witnessed by Jeremy Hawke, Director, and Dr Geoff Casson, General Manager, Kabwe.

 

Final Products

The Company also announces the successful recovery in testing by precipitation and electro winning from the PLS of the following products:

·      a lead sponge with a grade of 96% Pb

·      a rough zinc cathode with a grade of 98.72% Zn

·      a refined zinc cathode with a grade of 99.6% Zn

 

Imperial Smelting Furnace Slag (ISF Slag)

The Company was advised last year that the effective economic recovery of zinc from the ISF slag would prove difficult, being brittle and hard to process, and consequently the value of this resource was written off in the 2014 Annual Report.

The ISF slag had been estimated by Mineral Corporation Consultancy (Pty), in its March 2012 report to contain 1,481,563 dry tonnes (non-JORC) at a mean grade of 8.07% Zn (119.6kt contained Zn). 

As the ISF slag comprises a significant unexploited zinc resource, the Directors decided to re-examine the potential for the recovery of zinc from this source and we have been working closely with our consultants in order to assess commercial feasibility. Following recent mineralogical and exploratory metallurgical test work the Company is pleased to announce that, in conjunction with its Mineral Processing Partner, a recovery of 77.2% Zn has been successfully achieved in laboratory analysis. This metallurgical test work was also witnessed by Jeremy Hawke and Dr Geoff Casson.

Further work will now be undertaken to optimise this recovery and to establish if it can also be processed by the proposed flow sheet for the other Kabwe tailings and residues. In the event that this further work concludes positively, the Company will commission a JORC compliant survey of the ISF slag.

 

Pilot Plant Processes and Intellectual Property

The metallurgical processes that have been developed to achieve the recoveries and final products above are proprietary to BMR and your Directors are taking the appropriate steps to protect this intellectual property.  These processes are being incorporated into the design of the Kabwe pilot plant.

Subject to the approval of the Zambian Environmental Management Agency ("ZEMA") when finalised plans are submitted within the next four weeks, the Company intends to commence pilot plant operations in this financial year. It is also the intention of the Company to process first the higher-grade, higher-recovery WPT to generate initial returns from the Company's asset base.

Note:

This release has been reviewed by Geoff Casson, B.Sc. (Hons), PhD, R Eng (Zambia), Member Engineering Institute of Zambia (Metallurgy), General Manager of the Company's Zambian subsidiary, Enviro Processing Ltd, who is a Qualified Person in accordance with the guidance note for Mining, Oil & Gas Companies issued by the London Stock Exchange in respect of AIM Companies.

 

Ends

 

 

For further information:

BMR Mining PLC                                                                                                        020 7734 6252

Alex Borrelli, CEO and Chairman

 

WH Ireland Limited                                                                                                   020 7220 1666

Chris Fielding, Head of Corporate Finance

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCEAKXEDSNSEFF

Close

×

RNS Number : 8362T

Midatech Pharma PLC

23 July 2015

 

23 July 2015

 

Midatech Pharma PLC

("Midatech" or the "Company")

 

Initiation of Phase IIa study of insulin delivery via buccal strip for type 1 diabetes

 

Midatech (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in development, in partnership with MonoSol Rx, today announces that the first patient has been treated in a Phase IIa open label, cross-over, seven arm study of Insulin Buccal Soluble Film (MSL-001) for type 1 diabetes mellitus.

 

The objectives of the study are to establish the pharmacodynamic and pharmacokinetic profile, and safety and tolerability of MSL-001 (MidaForm® Insulin PharmFilm®) in comparison to subcutaneous administered human recombinant insulin (Humulin®).

 

The study is being conducted in Perth, Australia, with a total of 12 patients, male and female, aged 18 – 55 being treated from a screening pool of up to 35 subjects. The overall study duration is approximately five months.

 

MSL-001 contains recombinant human insulin which is non-covalently bound to glycan-coated gold nanoparticles and embedded in an oral, muco-adhesive, polymeric film for transbuccal delivery.  The drug was invented by Midatech and MonoSol Rx and is being developed by the parties' joint venture, MidaSol Therapeutics.

 

Commenting on the study, Dr. Jim Philips, CEO of Midatech Pharma, said: "Diabetes incidence is forecast to hit 500m people, globally, by 2025; with our partnered transbuccal insulin strip, MSL-001 is targeting a $20 billion market, adding significant revenue potential to our growing portfolio of products."

 

– Ends –

 

For more information, please contact:

 

Midatech Pharma PLC

Jim Phillips, CEO

Tel: +44 (0)1235 841575

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate Finance

Freddy Crossley / Adam James / Atholl Tweedie / Duncan Monteith

 

 

Broking

Tom Salvesen

Tel: +44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary Jane Elliott / Ivar Milligan / Matthew Neal / Hendrik Thys

Tel: +44 (0)20 3709 5700

Email: midatech@consilium-comms.com

 

 

About Midatech Pharma PLC

 

Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. These diseases include diabetes, rare cancers including brain (glioblastoma), ovarian, liver and pancreatic cancer and neurological/ophthalmologic conditions.  Midatech's strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

 

Midatech's core product candidates derive from its two multi-applicable platform technologies that can be used alone or in combination to enable the targeted delivery ('right place') and controlled release ('right time') of existing drugs. These technologies are provided through its wholly-owned subsidiaries, Midatech and Q-Chip (acquired in 2014).  Midatech's core platform is a drug conjugate delivery system based on a patented form of gold nanoparticles (GNP) combined with existing drugs for the safe and targeted release of therapeutic payloads at specific organs, cells or sites of disease.

The Group's second platform is a sustained release technology acquired with Q Chip that involves the consistent and precise encapsulation of active drug compounds within polymer microspheres enabling their release into the body in a highly controlled manner over a prolonged period of time.

On 4 June 2015, Midatech announced a proposed acquisition of DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company, based in Raleigh, NC. The acquisition brings a portfolio of marketed oncology products and a salesforce in US to Midatech and is expected to complete in H2 2015.

The Group is headquartered near Oxford, UK, with a nanoparticle manufacturing operation in Bilbao, Spain and an R&D facility in Cardiff, UK.  For further company information see: www.midatechgroup.com.

 

 

About MonoSol Rx

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to develop products which address the unmet needs of patients.  PharmFilm® is designed to benefit patients by improving the safety, efficacy, compliance and convenience of new and currently marketed drugs.  The Company's leadership in film drug delivery is supported by strong intellectual property, a pipeline of prescription formulations based on PharmFilm® technology, and two FDA approvals – Zuplenz®, the first approved prescription oral soluble film for the prevention of chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting, and Suboxone® sublingual film, the first sublingual film product for the treatment of opioid dependence.  For press releases and other company information visit: www.monosolrx.com.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCPGUPPMUPAUAW

Close

×

RNS Number : 4352T

Proton Power Systems PLC

20 July 2015

 

 

 

 

Proton Power Systems plc

 

("Proton" or the "Company")

 

 

Cooperation Agreement with German Rail subsidiary Bahnbau 

for sales and service of hydrogen fuel cell UPS systems

 

Proton Power Systems plc (AIM: PPS), the designer, developer and producer of fuel cells and fuel cell electric hybrid systems, is pleased to announce, that it signed a cooperation agreement with DB Bahnbau Gruppe GmbH ("Bahnbau"), the service company of German Rail ("DB") for rail network infrastructure installation and maintenance. Bahnbau will sell and install Proton's containerised fuel cell systems as UPS applications to DB and third party customers. DB is planning to replace the installed base of diesel generator UPS systems with zero emission fuel cell applications over the coming years.

 

Bahnbau will provide the site planning, installation and service for containerised systems from Proton. In addition to DB, Bahnbau will also offer those solutions to other third party customers in industries like IT, transport and manufacturing. Bahnbau (www.bahnbaugruppe.de) has one of the largest technical service organisations in Germany.

 

The decision to replace old diesel systems is not only based on environmental aspects but also on commercial aspects. High maintenance cost for old diesel installations makes it more commercially viable for DB installations to use the new fuel cell technology. Proton will supply complete containerised solutions with the fuel cell, switchgear, cooling and UPS system for a power demand from 6 to 250kW.

 

Faiz Francoise Nahab, CEO of Proton, said: "This is a key milestone for our company and fits well within the recent expansion of our manufacturing facilities enabling large quantity manufacturing capacity. To work with experts like Bahnbau is something we always had in mind. The decision of DB to use fuel cell UPS systems to replace old diesel applications is also to be seen as a milestone for our industry. Not only has the environmental aspect driven that decision but also commercial considerations, which is very important for our industry."

 

– Ends –

 

 

 

 

For further information:

Proton Power Systems plc
Dr Faiz Nahab, CEO
Achim Loecher, FD Ian Peden, Chairman	Tel: +49 (0) 89 127 626 550 Tel: +49 (0) 162 101 6470
	www.protonpowersystems.com

 

Westhouse Securities Limited Nominated adviser and broker	Tel: +44 (0) 20 7601 6100
Antonio Bossi / David Coaten	www.westhousesecurities.com

 

 

About Proton Motor Fuel Cell GmbH

Proton Motor is an expert in industrial fuel cells, fuel cell and hybrid systems with more than 17 years of experience in this sector.  Based in Puchheim near Munich, Proton Motor offers complete fuel cell and hybrid systems from a single source – from the development and production through the implementation of customized solutions.  The focus of Proton Motor is on back-to-base, for example, for mobile, marine and stationary solutions applications.  The product portfolio consists of base-fuel cell systems, standard complete systems, as well as customized systems.

 

Proton Motor acquired SPower GmbH in 2013. Established in 2007, SPower serves IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East with power supply solutions for DC and AC power demand. In addition to power supply, SPower also offers solutions for Solar Systems as well as a new product line for Solar Energy Storage.

 

Proton Motor Fuel Cells GmbH is wholly owned subsidiary of Proton Power Systems plc.  The Company has been listed on the London Stock Exchange since October 2006 (code: PPS).

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRPKODPPBKDDOD

Close

×

Orchard Funding Group is delighted to announce that its subsidiary Bexhill UK Limited has been granted full Financial Conduct Authority ("FCA") permission to conduct business as a consumer credit lender and credit broker. Orchard Funding Group is considered the first insurance premium finance lender and professional fee funder in the UK to obtain full FCA consumer lending permissions.

FCA permission follows on from the Company's recent flotation on the London Stock Exchange earlier this month and together they reflect the past success of the business and the growing reputation and potential of the Company going forward. Trust is a key component of doing business and for those companies from the insurance sector or the professions sector looking for a finance provider; the Directors believe that the FCA permission will be a key point of differentiation.

Orchard Funding Group is also delighted to announce that its subsidiary Bexhill UK Limited has become a consumer credit Principal – Appointed Representative, considered the first in the UK to obtain this status. This will enable credit brokers of unsecured credit to avoid the expense and burden of direct FCA regulation by becoming an Appointed Representative of Bexhill UK Limited. Bexhill UK Limited can now offer this facility to unsecured credit brokers in the UK and intends to market this service to enable them to take advantage of Bexhill's Appointed Representative Network.

Ravi Takhar, Chief Executive Officer of Orchard Funding Group stated, "We are very pleased to receive the great news of Bexhill UK's obtaining full FCA permission for consumer credit lending and consumer credit brokerage. We are also delighted to become one of the first consumer credit Principal-Appointed Representative in the UK and hope to provide assistance to consumer credit brokers by helping with the burden of FCA regulation. July has been a great for us with the combination of achieving both a London Stock Exchange listing and full FCA permission – it could not have been a better month."

 

For further information please contact

Orchard Funding Group PLC                                                                   +44 (0)1582 635 507

Ravi Takhar, Chief Executive Officer

 

Panmure Gordon Limited (Nomad and Broker)                                      +44 (0)20 7886 2500

Dominic Morley (Corporate Finance)

Adam James (Corporate Finance)

Alina Vaskina (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)

 

Novella                                                                                                        +44 (0)20 3151 7008

Tim Robertson

Ben Heath

               

For Investor Relations please go to: www.orchardfundinggroupplc.com

 

Close